Total lesion glycolysis by 18F-FDG PET/CT is independent prognostic factor in patients with advanced non-small cell lung cancer
CLINICAL RESPIRATORY JOURNAL, cilt.11, sa.5, ss.602-611, 2017 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 11 Sayı: 5
- Basım Tarihi: 2017
- Doi Numarası: 10.1111/crj.12391
- Dergi Adı: CLINICAL RESPIRATORY JOURNAL
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.602-611
- Anahtar Kelimeler: median tumor volume, non-small cell lung cancer, SUVmax, total lesion glycolysis, POSITRON-EMISSION-TOMOGRAPHY, METABOLIC TUMOR VOLUME, STANDARDIZED UPTAKE VALUE, MALIGNANT PLEURAL MESOTHELIOMA, FDG-PET/CT, RESPONSE EVALUATION, F-18-FDG PET/CT, RECTAL-CANCER, STAGE, SURVIVAL
- Gazi Üniversitesi Adresli: Evet
Özet
Background and AimsTo determine whether the primary tumor SUVmax and total lesion glycolysis (TLG) measured on F-18-FDG PET/CT have prognostic significance in patients with non-small-cell lung cancer (NSCLC).